APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lisdexamfetamine Dimesylate Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lisdexamfetamine Dimesylate Capsules Industry Growth and Trends Forecast to 2032

27 December 2025103 pages

Choose your research edition.

Industry ResearchLisdexamfetamine Dimesylate Capsules Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Lisdexamfetamine Dimesylate Capsules Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Lisdexamfetamine Dimesylate Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lisdexamfetamine Dimesylate Capsules Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lisdexamfetamine Dimesylate Capsules Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Lisdexamfetamine Dimesylate Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lisdexamfetamine Dimesylate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lisdexamfetamine Dimesylate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lisdexamfetamine Dimesylate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lisdexamfetamine Dimesylate Capsules include Zhejiang Huahai Pharmaceutical, Sun Pharmaceutical, Takeda Pharmaceutical, Teva Pharmaceutical, Sandoz, Mylan, Mallinckrodt PLC, Lannett and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lisdexamfetamine Dimesylate Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lisdexamfetamine Dimesylate Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lisdexamfetamine Dimesylate Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lisdexamfetamine Dimesylate Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lisdexamfetamine Dimesylate Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lisdexamfetamine Dimesylate Capsules Market by Company

Zhejiang Huahai Pharmaceutical

Sun Pharmaceutical

Takeda Pharmaceutical

Teva Pharmaceutical

Sandoz

Mylan

Mallinckrodt PLC

Lannett

Hikma Pharmaceuticals

Ascent Pharmaceuticals

Apotex

Amneal Pharmaceuticals

Alkem Laboratories

Lisdexamfetamine Dimesylate Capsules Segment by Type

10mg per Unit

20mg per Unit

30mg per Unit

40mg per Unit

50mg per Unit

60mg per Unit

70mg per Unit

Lisdexamfetamine Dimesylate Capsules Segment by Application

Attention Deficit Hyperactivity Disorder(ADHD)

Bulimia

Other

Lisdexamfetamine Dimesylate Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lisdexamfetamine Dimesylate Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lisdexamfetamine Dimesylate Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lisdexamfetamine Dimesylate Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lisdexamfetamine Dimesylate Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lisdexamfetamine Dimesylate Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mg per Unit Table 2. Major Company of 20mg per Unit Table 3. Major Company of 30mg per Unit Table 4. Major Company of 40mg per Unit Table 5. Major Company of 50mg per Unit Table 6. Major Company of 60mg per Unit Table 7. Major Company of 70mg per Unit Table 8. Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (K Units) Table 10. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Type (2021-2026) Table 11. Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (US$ Million) Table 12. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Type (2021-2026) Table 13. Global Lisdexamfetamine Dimesylate Capsules Price by Type (2021-2026) & (US$/Unit) Table 14. Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2027-2032) & (K Units) Table 15. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Type (2027-2032) Table 16. Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2027-2032) & (US$ Million) Table 17. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Type (2027-2032) Table 18. Global Lisdexamfetamine Dimesylate Capsules Price by Type (2027-2032) & (US$/Unit) Table 19. North America Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (K Units) Table 20. North America Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (K Units) Table 22. Europe Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (K Units) Table 24. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (K Units) Table 26. Latin America Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (K Units) Table 28. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (US$ Million) Table 29. Lisdexamfetamine Dimesylate Capsules Industry Trends Table 30. Lisdexamfetamine Dimesylate Capsules Industry Drivers Table 31. Lisdexamfetamine Dimesylate Capsules Industry Opportunities and Challenges Table 32. Lisdexamfetamine Dimesylate Capsules Industry Restraints Table 33. Global Lisdexamfetamine Dimesylate Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Company (2021-2026) Table 35. Global Lisdexamfetamine Dimesylate Capsules Sales by Company (2021-2026) & (K Units) Table 36. Global Lisdexamfetamine Dimesylate Capsules Sales Share by Company (2021-2026) Table 37. Global Lisdexamfetamine Dimesylate Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global Lisdexamfetamine Dimesylate Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Lisdexamfetamine Dimesylate Capsules Major Company Production Sites and Headquarters Table 40. Global Lisdexamfetamine Dimesylate Capsules Company, Product Type & Application Table 41. Global Lisdexamfetamine Dimesylate Capsules Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Lisdexamfetamine Dimesylate Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Lisdexamfetamine Dimesylate Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2021-2026) & (K Units) Table 46. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Region (2021-2026) Table 47. Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2021-2026) & (US$ Million) Table 48. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Region (2021-2026) Table 49. Global Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2027-2032) & (K Units) Table 51. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Region (2027-2032) Table 52. Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2027-2032) & (US$ Million) Table 53. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Region (2027-2032) Table 54. Global Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (K Units) Table 57. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Application (2021-2026) Table 58. Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (US$ Million) Table 59. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Application (2021-2026) Table 60. Global Lisdexamfetamine Dimesylate Capsules Price by Application (2021-2026) & (US$/Unit) Table 61. Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2027-2032) & (K Units) Table 62. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Application (2027-2032) Table 63. Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2027-2032) & (US$ Million) Table 64. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Application (2027-2032) Table 65. Global Lisdexamfetamine Dimesylate Capsules Price by Application (2027-2032) & (US$/Unit) Table 66. North America Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (K Units) Table 67. North America Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (K Units) Table 69. Europe Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (K Units) Table 71. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (K Units) Table 73. Latin America Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (K Units) Table 75. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (US$ Million) Table 76. Zhejiang Huahai Pharmaceutical Company Information Table 77. Zhejiang Huahai Pharmaceutical Business Overview Table 78. Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 80. Zhejiang Huahai Pharmaceutical Recent Development Table 81. Sun Pharmaceutical Company Information Table 82. Sun Pharmaceutical Business Overview Table 83. Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 85. Sun Pharmaceutical Recent Development Table 86. Takeda Pharmaceutical Company Information Table 87. Takeda Pharmaceutical Business Overview Table 88. Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 90. Takeda Pharmaceutical Recent Development Table 91. Teva Pharmaceutical Company Information Table 92. Teva Pharmaceutical Business Overview Table 93. Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 95. Teva Pharmaceutical Recent Development Table 96. Sandoz Company Information Table 97. Sandoz Business Overview Table 98. Sandoz Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sandoz Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 100. Sandoz Recent Development Table 101. Mylan Company Information Table 102. Mylan Business Overview Table 103. Mylan Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Mylan Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 105. Mylan Recent Development Table 106. Mallinckrodt PLC Company Information Table 107. Mallinckrodt PLC Business Overview Table 108. Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 110. Mallinckrodt PLC Recent Development Table 111. Lannett Company Information Table 112. Lannett Business Overview Table 113. Lannett Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Lannett Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 115. Lannett Recent Development Table 116. Hikma Pharmaceuticals Company Information Table 117. Hikma Pharmaceuticals Business Overview Table 118. Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 120. Hikma Pharmaceuticals Recent Development Table 121. Ascent Pharmaceuticals Company Information Table 122. Ascent Pharmaceuticals Business Overview Table 123. Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 125. Ascent Pharmaceuticals Recent Development Table 126. Apotex Company Information Table 127. Apotex Business Overview Table 128. Apotex Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Apotex Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 130. Apotex Recent Development Table 131. Amneal Pharmaceuticals Company Information Table 132. Amneal Pharmaceuticals Business Overview Table 133. Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 135. Amneal Pharmaceuticals Recent Development Table 136. Alkem Laboratories Company Information Table 137. Alkem Laboratories Business Overview Table 138. Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 140. Alkem Laboratories Recent Development Table 141. North America Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. North America Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026) & (K Units) Table 143. North America Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2021-2026) Table 144. North America Lisdexamfetamine Dimesylate Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 145. North America Lisdexamfetamine Dimesylate Capsules Sales Market Share Forecast by Country (2027-2032) Table 146. North America Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Lisdexamfetamine Dimesylate Capsules Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Lisdexamfetamine Dimesylate Capsules Market Share by Country (2021-2026) Table 149. North America Lisdexamfetamine Dimesylate Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Lisdexamfetamine Dimesylate Capsules Market Share Forecast by Country (2027-2032) Table 151. Europe Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Europe Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026) & (K Units) Table 153. Europe Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2021-2026) Table 154. Europe Lisdexamfetamine Dimesylate Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 155. Europe Lisdexamfetamine Dimesylate Capsules Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Lisdexamfetamine Dimesylate Capsules Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Lisdexamfetamine Dimesylate Capsules Market Share by Country (2021-2026) Table 159. Europe Lisdexamfetamine Dimesylate Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Lisdexamfetamine Dimesylate Capsules Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026) & (K Units) Table 163. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 165. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Share by Country (2021-2026) Table 169. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Share Forecast by Country (2027-2032) Table 171. Latin America Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Latin America Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026) & (K Units) Table 173. Latin America Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2021-2026) Table 174. Latin America Lisdexamfetamine Dimesylate Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 175. Latin America Lisdexamfetamine Dimesylate Capsules Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Lisdexamfetamine Dimesylate Capsules Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Lisdexamfetamine Dimesylate Capsules Market Share by Country (2021-2026) Table 179. Latin America Lisdexamfetamine Dimesylate Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Lisdexamfetamine Dimesylate Capsules Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026) & (K Units) Table 183. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 185. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Share by Country (2021-2026) Table 189. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Lisdexamfetamine Dimesylate Capsules Distributors List Table 194. Lisdexamfetamine Dimesylate Capsules Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Lisdexamfetamine Dimesylate Capsules Image Figure 2. Global Lisdexamfetamine Dimesylate Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lisdexamfetamine Dimesylate Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Lisdexamfetamine Dimesylate Capsules Sales (2021-2032) & (K Units) Figure 5. 10mg per Unit Image Figure 6. Global 10mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 7. 20mg per Unit Image Figure 8. Global 20mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 9. 30mg per Unit Image Figure 10. Global 30mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 11. 40mg per Unit Image Figure 12. Global 40mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 13. 50mg per Unit Image Figure 14. Global 50mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 15. 60mg per Unit Image Figure 16. Global 60mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 17. 70mg per Unit Image Figure 18. Global 70mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 19. Global Lisdexamfetamine Dimesylate Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Lisdexamfetamine Dimesylate Capsules Market Share by Type 2025 VS 2032 Figure 21. North America Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Type in 2025 Figure 22. North America Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Type in 2025 Figure 23. Europe Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Type in 2025 Figure 24. Europe Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Type in 2025 Figure 27. Latin America Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Lisdexamfetamine Dimesylate Capsules Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Attention Deficit Hyperactivity Disorder(ADHD) Image Figure 34. Global Attention Deficit Hyperactivity Disorder(ADHD) Sales YoY Growth (2021-2032) & (K Units) Figure 35. Bulimia Image Figure 36. Global Bulimia Sales YoY Growth (2021-2032) & (K Units) Figure 37. Other Image Figure 38. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Lisdexamfetamine Dimesylate Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Lisdexamfetamine Dimesylate Capsules Market Share by Application 2025 VS 2032 Figure 41. North America Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Application in 2025 Figure 42. North America Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Application in 2025 Figure 43. Europe Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Application in 2025 Figure 44. Europe Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Application in 2025 Figure 47. Latin America Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Market Share in Value by Application in 2025 Figure 51. North America Lisdexamfetamine Dimesylate Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Lisdexamfetamine Dimesylate Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Lisdexamfetamine Dimesylate Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Lisdexamfetamine Dimesylate Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Lisdexamfetamine Dimesylate Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Lisdexamfetamine Dimesylate Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Lisdexamfetamine Dimesylate Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Lisdexamfetamine Dimesylate Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Lisdexamfetamine Dimesylate Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Lisdexamfetamine Dimesylate Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Lisdexamfetamine Dimesylate Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Lisdexamfetamine Dimesylate Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Lisdexamfetamine Dimesylate Capsules Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Lisdexamfetamine Dimesylate Capsules Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg per Unit
  • 20mg per Unit
  • 30mg per Unit
  • 40mg per Unit
  • 50mg per Unit
  • 60mg per Unit
  • 70mg per Unit
Applications
  • Attention Deficit Hyperactivity Disorder(ADHD)
  • Bulimia
  • Other
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Sun Pharmaceutical
  • Takeda Pharmaceutical
  • Teva Pharmaceutical
  • Sandoz
  • Mylan
  • Mallinckrodt PLC
  • Lannett
  • Hikma Pharmaceuticals
  • Ascent Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Alkem Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lisdexamfetamine Dimesylate Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lisdexamfetamine Dimesylate Capsules Market by Type
  6. 1.3.1 10mg per Unit
  7. 1.3.2 20mg per Unit
  8. 1.3.3 30mg per Unit
  9. 1.3.4 40mg per Unit
  10. 1.3.5 50mg per Unit
  11. 1.3.6 60mg per Unit
  12. 1.3.7 70mg per Unit
  13. 1.4 Global Lisdexamfetamine Dimesylate Capsules Market Size by Type
  14. 1.4.1 Global Lisdexamfetamine Dimesylate Capsules Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Lisdexamfetamine Dimesylate Capsules Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Lisdexamfetamine Dimesylate Capsules Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Lisdexamfetamine Dimesylate Capsules Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Lisdexamfetamine Dimesylate Capsules Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Lisdexamfetamine Dimesylate Capsules Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lisdexamfetamine Dimesylate Capsules Industry Trends
  2. 2.2 Lisdexamfetamine Dimesylate Capsules Industry Drivers
  3. 2.3 Lisdexamfetamine Dimesylate Capsules Industry Opportunities and Challenges
  4. 2.4 Lisdexamfetamine Dimesylate Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lisdexamfetamine Dimesylate Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Lisdexamfetamine Dimesylate Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Lisdexamfetamine Dimesylate Capsules Price (2021-2026)
  4. 3.4 Global Lisdexamfetamine Dimesylate Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lisdexamfetamine Dimesylate Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Lisdexamfetamine Dimesylate Capsules Company, Product Type & Application
  7. 3.7 Global Lisdexamfetamine Dimesylate Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lisdexamfetamine Dimesylate Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lisdexamfetamine Dimesylate Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lisdexamfetamine Dimesylate Capsules Tier 1, Tier 2, and Tier 3
4 Lisdexamfetamine Dimesylate Capsules Regional Status and Outlook
  1. 4.1 Global Lisdexamfetamine Dimesylate Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lisdexamfetamine Dimesylate Capsules Historic Market Size by Region
  3. 4.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lisdexamfetamine Dimesylate Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lisdexamfetamine Dimesylate Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Lisdexamfetamine Dimesylate Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lisdexamfetamine Dimesylate Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lisdexamfetamine Dimesylate Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lisdexamfetamine Dimesylate Capsules by Application
  1. 5.1 Lisdexamfetamine Dimesylate Capsules Market by Application
  2. 5.1.1 Attention Deficit Hyperactivity Disorder(ADHD)
  3. 5.1.2 Bulimia
  4. 5.1.3 Other
  5. 5.2 Global Lisdexamfetamine Dimesylate Capsules Market Size by Application
  6. 5.2.1 Global Lisdexamfetamine Dimesylate Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Lisdexamfetamine Dimesylate Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Lisdexamfetamine Dimesylate Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Lisdexamfetamine Dimesylate Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Lisdexamfetamine Dimesylate Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Lisdexamfetamine Dimesylate Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Huahai Pharmaceutical
  2. 6.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 6.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 6.1.3 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  6. 6.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 6.2 Sun Pharmaceutical
  8. 6.2.1 Sun Pharmaceutical Company Information
  9. 6.2.2 Sun Pharmaceutical Business Overview
  10. 6.2.3 Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Recent Developments
  13. 6.3 Takeda Pharmaceutical
  14. 6.3.1 Takeda Pharmaceutical Company Information
  15. 6.3.2 Takeda Pharmaceutical Business Overview
  16. 6.3.3 Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  18. 6.3.5 Takeda Pharmaceutical Recent Developments
  19. 6.4 Teva Pharmaceutical
  20. 6.4.1 Teva Pharmaceutical Company Information
  21. 6.4.2 Teva Pharmaceutical Business Overview
  22. 6.4.3 Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  24. 6.4.5 Teva Pharmaceutical Recent Developments
  25. 6.5 Sandoz
  26. 6.5.1 Sandoz Company Information
  27. 6.5.2 Sandoz Business Overview
  28. 6.5.3 Sandoz Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sandoz Lisdexamfetamine Dimesylate Capsules Product Portfolio
  30. 6.5.5 Sandoz Recent Developments
  31. 6.6 Mylan
  32. 6.6.1 Mylan Company Information
  33. 6.6.2 Mylan Business Overview
  34. 6.6.3 Mylan Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mylan Lisdexamfetamine Dimesylate Capsules Product Portfolio
  36. 6.6.5 Mylan Recent Developments
  37. 6.7 Mallinckrodt PLC
  38. 6.7.1 Mallinckrodt PLC Company Information
  39. 6.7.2 Mallinckrodt PLC Business Overview
  40. 6.7.3 Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Product Portfolio
  42. 6.7.5 Mallinckrodt PLC Recent Developments
  43. 6.8 Lannett
  44. 6.8.1 Lannett Company Information
  45. 6.8.2 Lannett Business Overview
  46. 6.8.3 Lannett Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lannett Lisdexamfetamine Dimesylate Capsules Product Portfolio
  48. 6.8.5 Lannett Recent Developments
  49. 6.9 Hikma Pharmaceuticals
  50. 6.9.1 Hikma Pharmaceuticals Company Information
  51. 6.9.2 Hikma Pharmaceuticals Business Overview
  52. 6.9.3 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
  54. 6.9.5 Hikma Pharmaceuticals Recent Developments
  55. 6.10 Ascent Pharmaceuticals
  56. 6.10.1 Ascent Pharmaceuticals Company Information
  57. 6.10.2 Ascent Pharmaceuticals Business Overview
  58. 6.10.3 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
  60. 6.10.5 Ascent Pharmaceuticals Recent Developments
  61. 6.11 Apotex
  62. 6.11.1 Apotex Company Information
  63. 6.11.2 Apotex Business Overview
  64. 6.11.3 Apotex Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Apotex Lisdexamfetamine Dimesylate Capsules Product Portfolio
  66. 6.11.5 Apotex Recent Developments
  67. 6.12 Amneal Pharmaceuticals
  68. 6.12.1 Amneal Pharmaceuticals Company Information
  69. 6.12.2 Amneal Pharmaceuticals Business Overview
  70. 6.12.3 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
  72. 6.12.5 Amneal Pharmaceuticals Recent Developments
  73. 6.13 Alkem Laboratories
  74. 6.13.1 Alkem Laboratories Company Information
  75. 6.13.2 Alkem Laboratories Business Overview
  76. 6.13.3 Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Product Portfolio
  78. 6.13.5 Alkem Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Lisdexamfetamine Dimesylate Capsules Sales by Country
  2. 7.1.1 North America Lisdexamfetamine Dimesylate Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Lisdexamfetamine Dimesylate Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lisdexamfetamine Dimesylate Capsules Market Size by Country
  6. 7.2.1 North America Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lisdexamfetamine Dimesylate Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Lisdexamfetamine Dimesylate Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lisdexamfetamine Dimesylate Capsules Sales by Country
  2. 8.1.1 Europe Lisdexamfetamine Dimesylate Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Lisdexamfetamine Dimesylate Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lisdexamfetamine Dimesylate Capsules Market Size by Country
  6. 8.2.1 Europe Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lisdexamfetamine Dimesylate Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lisdexamfetamine Dimesylate Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lisdexamfetamine Dimesylate Capsules Sales by Country
  2. 10.1.1 South America Lisdexamfetamine Dimesylate Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Lisdexamfetamine Dimesylate Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lisdexamfetamine Dimesylate Capsules Market Size by Country
  6. 10.2.1 South America Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lisdexamfetamine Dimesylate Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Lisdexamfetamine Dimesylate Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lisdexamfetamine Dimesylate Capsules Value Chain Analysis
  2. 12.1.1 Lisdexamfetamine Dimesylate Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lisdexamfetamine Dimesylate Capsules Production Mode & Process
  7. 12.2 Lisdexamfetamine Dimesylate Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lisdexamfetamine Dimesylate Capsules Distributors
  10. 12.2.3 Lisdexamfetamine Dimesylate Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst